Harvard Bioscience (HBIO) Return on Capital Employed Growth (3y) (2014 - 2026)
Harvard Bioscience (HBIO) Return on Capital Employed Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.58 Bn | 121.36 Bn | 1.96 Bn | 500.00 |
| 2 | Becton Dickinson | 44.84 Bn | 44.03 Bn | 2.15 Bn | 20.00 |
| 3 | Medline | 32.91 Bn | 30.68 Bn | 1.84 Bn | - |
| 4 | Alcon | 32.91 Bn | 31.25 Bn | 1.53 Bn | 2,114.00 |
| 5 | Resmed | 29.47 Bn | 27.81 Bn | 890.98 Mn | 721.00 |
| 6 | West Pharmaceutical Services | 23.44 Bn | 23.00 Bn | 329.20 Mn | -82.00 |
| 7 | Solventum | 14.06 Bn | 13.49 Bn | 1.10 Bn | - |
| 8 | Cooper Companies | 13.78 Bn | 13.65 Bn | 735.40 Mn | 5.00 |
| 9 | Align Technology | 12.04 Bn | 10.98 Bn | 736.59 Mn | -200.00 |
| 10 | Harvard Bioscience | 27.26 Mn | 20.16 Mn | 12.24 Mn | -141.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -141.00 |
| Dec 31, 2025 | -7,948.00 |
| Sep 30, 2025 | -20,032.00 |
| Jun 30, 2025 | -21,121.00 |
| Mar 31, 2025 | -10,924.00 |
| Dec 31, 2024 | -995.00 |
| Sep 30, 2024 | -793.00 |
| Jun 30, 2024 | -674.00 |
| Mar 31, 2024 | -439.00 |
| Dec 31, 2023 | 152.00 |
| Sep 30, 2023 | 169.00 |
| Jun 30, 2023 | 49.00 |
| Mar 31, 2023 | 328.00 |
| Dec 31, 2022 | -591.00 |
| Sep 30, 2022 | -402.00 |
| Jun 30, 2022 | -220.00 |
| Mar 31, 2022 | -477.00 |
| Dec 31, 2021 | 86.00 |
| Sep 30, 2021 | 266.00 |
| Jun 30, 2021 | 327.00 |